0001891669-21-000001.txt : 20211102
0001891669-21-000001.hdr.sgml : 20211102
20211102130429
ACCESSION NUMBER: 0001891669-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211102
DATE AS OF CHANGE: 20211102
EFFECTIVENESS DATE: 20211102
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Red Queen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001891669
IRS NUMBER: 872028563
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-419494
FILM NUMBER: 211370109
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 203-232-7865
MAIL ADDRESS:
STREET 1: 245 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
D
1
primary_doc.xml
X0708
D
LIVE
0001891669
Red Queen Therapeutics, Inc.
245 MAIN STREET
CAMBRIDGE
MA
MASSACHUSETTS
02142
203-232-7865
DELAWARE
None
None
Corporation
true
2021
Paul
Da Silva Jardine
c/o Red Queen Therapeutics, Inc.
245 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Seth
Harrison
c/o Red Queen Therapeutics, Inc.
245 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Spiros
Liras
c/o Red Queen Therapeutics, Inc.
245 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Loren
Walensky
c/o Red Queen Therapeutics, Inc.
245 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-10-13
false
true
false
0
55000000
5000000
50000000
false
1
0
0
0
false
Red Queen Therapeutics, Inc.
/s/ Paul Da Silva Jardine
Paul Da Silva Jardine
President
2021-11-02